Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...

In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...

The Provincial Government of Pampanga has announced the availability of Human Immunodeficiency Virus (HIV) testing and treatment centers across the province. Th ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

The Johns Hopkins team that conducted the new study had previously shown that the molecule of interest, an “antisense ...

Australian researchers have taken a major step towards an HIV cure by devising a method to deliver an mRNA-based therapy direct to cells to expose the dormant virus where it hides.. Major advances ...